GORE® C3 Delivery System Approved In Japan
03 December 2013
- System Enables Physicians and Interventionalists to Reposition GORE® EXCLUDER® AAA Endoprosthesis for Ideal Placement in Treating Abdominal Aortic Aneurysms
Gore Launches Improved GORE® HELEX Delivery System in Europe
12 July 2010
- W. L. Gore & Associates is pleased to announce the availability of an improved iteration of the
GORE® HELEX Septal Occluder. The rollout of the improvement will begin in Europe immediately,
and its availability will open up to other markets pending respective regulatory approvals.
Gore REVISE Study Receives Approval From FDA
07 April 2008
- The Gore REVISE Study is a randomized, multi-center clinical trial intended to establish efficacy and safety of the GORE VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface to revise arterio-venous grafts at the venous anastomosis in hemodialysis patients.
Gore REVISE Study Receives Conditional Approval From FDA
12 July 2007
- Conditional approval to proceed with the Gore REVISE (VasculaR
ision with GORE VI
thesis vs PercutanE
ous Transluminal Angioplasty) Study was announced today by W. L. Gore & Associates.